CN114514973B - 一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法 - Google Patents
一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法 Download PDFInfo
- Publication number
- CN114514973B CN114514973B CN202210145128.1A CN202210145128A CN114514973B CN 114514973 B CN114514973 B CN 114514973B CN 202210145128 A CN202210145128 A CN 202210145128A CN 114514973 B CN114514973 B CN 114514973B
- Authority
- CN
- China
- Prior art keywords
- liver
- fermentation
- parts
- sobering
- beverage
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 43
- 235000019985 fermented beverage Nutrition 0.000 title claims abstract description 23
- 230000002633 protecting effect Effects 0.000 title claims abstract description 20
- 238000002360 preparation method Methods 0.000 title claims abstract description 15
- 150000001875 compounds Chemical class 0.000 title abstract description 27
- 230000000694 effects Effects 0.000 claims abstract description 59
- 244000046146 Pueraria lobata Species 0.000 claims abstract description 32
- 235000010575 Pueraria lobata Nutrition 0.000 claims abstract description 32
- 235000013361 beverage Nutrition 0.000 claims abstract description 29
- 239000002131 composite material Substances 0.000 claims abstract description 15
- 238000000855 fermentation Methods 0.000 claims description 41
- 230000004151 fermentation Effects 0.000 claims description 41
- 230000001954 sterilising effect Effects 0.000 claims description 20
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 238000002156 mixing Methods 0.000 claims description 12
- 238000002791 soaking Methods 0.000 claims description 12
- 238000011049 filling Methods 0.000 claims description 11
- 235000012907 honey Nutrition 0.000 claims description 10
- 239000000463 material Substances 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 10
- 235000009008 Eriobotrya japonica Nutrition 0.000 claims description 9
- 244000010000 Hovenia dulcis Species 0.000 claims description 9
- 235000008584 Hovenia dulcis Nutrition 0.000 claims description 9
- 241000026010 Dendrobium candidum Species 0.000 claims description 8
- 244000111489 Gardenia augusta Species 0.000 claims description 8
- 239000006228 supernatant Substances 0.000 claims description 8
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 7
- 241000186660 Lactobacillus Species 0.000 claims description 7
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 7
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 7
- 235000021552 granulated sugar Nutrition 0.000 claims description 7
- 229940039696 lactobacillus Drugs 0.000 claims description 7
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 7
- 238000001816 cooling Methods 0.000 claims description 6
- 239000002504 physiological saline solution Substances 0.000 claims description 6
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 claims description 5
- YIKYNHJUKRTCJL-UHFFFAOYSA-N Ethyl maltol Chemical compound CCC=1OC=CC(=O)C=1O YIKYNHJUKRTCJL-UHFFFAOYSA-N 0.000 claims description 5
- 229940093503 ethyl maltol Drugs 0.000 claims description 5
- 239000012467 final product Substances 0.000 claims description 5
- 239000004302 potassium sorbate Substances 0.000 claims description 5
- 235000010241 potassium sorbate Nutrition 0.000 claims description 5
- 229940069338 potassium sorbate Drugs 0.000 claims description 5
- 239000011550 stock solution Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 241000894006 Bacteria Species 0.000 claims description 2
- 244000061508 Eriobotrya japonica Species 0.000 claims 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium erythorbate Chemical compound [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims 1
- 235000010352 sodium erythorbate Nutrition 0.000 claims 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 45
- KJXSIXMJHKAJOD-LSDHHAIUSA-N (+)-dihydromyricetin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC(O)=C(O)C(O)=C1 KJXSIXMJHKAJOD-LSDHHAIUSA-N 0.000 abstract description 6
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N daidzein Chemical compound C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 230000001737 promoting effect Effects 0.000 abstract description 4
- RXUWDKBZZLIASQ-UHFFFAOYSA-N Puerarin Natural products OCC1OC(Oc2c(O)cc(O)c3C(=O)C(=COc23)c4ccc(O)cc4)C(O)C(O)C1O RXUWDKBZZLIASQ-UHFFFAOYSA-N 0.000 abstract description 3
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 abstract description 3
- 235000007240 daidzein Nutrition 0.000 abstract description 3
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 3
- 229930003944 flavone Natural products 0.000 abstract description 3
- 150000002212 flavone derivatives Chemical class 0.000 abstract description 3
- 235000011949 flavones Nutrition 0.000 abstract description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 abstract description 3
- 235000013824 polyphenols Nutrition 0.000 abstract description 3
- HKEAFJYKMMKDOR-VPRICQMDSA-N puerarin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=CC(C2=O)=C1OC=C2C1=CC=C(O)C=C1 HKEAFJYKMMKDOR-VPRICQMDSA-N 0.000 abstract description 3
- 210000002784 stomach Anatomy 0.000 abstract description 3
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 abstract description 3
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 abstract description 2
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 abstract description 2
- 239000004480 active ingredient Substances 0.000 abstract description 2
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 abstract description 2
- 238000000354 decomposition reaction Methods 0.000 abstract description 2
- 210000003734 kidney Anatomy 0.000 abstract description 2
- 210000000952 spleen Anatomy 0.000 abstract description 2
- 241000700159 Rattus Species 0.000 description 37
- 230000000052 comparative effect Effects 0.000 description 22
- 210000002966 serum Anatomy 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 11
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 11
- 108010081577 aldehyde dehydrogenase (NAD(P)+) Proteins 0.000 description 11
- 239000003814 drug Substances 0.000 description 9
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 8
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 8
- 241001092070 Eriobotrya Species 0.000 description 8
- 108010082126 Alanine transaminase Proteins 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 7
- 230000002075 anti-alcohol Effects 0.000 description 7
- 208000007848 Alcoholism Diseases 0.000 description 6
- 206010067125 Liver injury Diseases 0.000 description 6
- 201000007930 alcohol dependence Diseases 0.000 description 6
- 230000035622 drinking Effects 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- 231100000753 hepatic injury Toxicity 0.000 description 6
- 210000005229 liver cell Anatomy 0.000 description 6
- 102100036475 Alanine aminotransferase 1 Human genes 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- 230000001476 alcoholic effect Effects 0.000 description 5
- 230000001953 sensory effect Effects 0.000 description 5
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 4
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 230000037396 body weight Effects 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 239000006041 probiotic Substances 0.000 description 4
- 235000018291 probiotics Nutrition 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 230000001603 reducing effect Effects 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 229910052708 sodium Inorganic materials 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 239000011718 vitamin C Substances 0.000 description 4
- 208000022309 Alcoholic Liver disease Diseases 0.000 description 3
- 230000003213 activating effect Effects 0.000 description 3
- 239000003963 antioxidant agent Substances 0.000 description 3
- 230000003078 antioxidant effect Effects 0.000 description 3
- 235000006708 antioxidants Nutrition 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 210000003855 cell nucleus Anatomy 0.000 description 3
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000008595 infiltration Effects 0.000 description 3
- 238000001764 infiltration Methods 0.000 description 3
- 208000019423 liver disease Diseases 0.000 description 3
- 230000036542 oxidative stress Effects 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 102000009027 Albumins Human genes 0.000 description 2
- 108010088751 Albumins Proteins 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- WZUVPPKBWHMQCE-UHFFFAOYSA-N Haematoxylin Chemical compound C12=CC(O)=C(O)C=C2CC2(O)C1C1=CC=C(O)C(O)=C1OC2 WZUVPPKBWHMQCE-UHFFFAOYSA-N 0.000 description 2
- 238000010171 animal model Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 208000019425 cirrhosis of liver Diseases 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000004090 dissolution Methods 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 208000006454 hepatitis Diseases 0.000 description 2
- 231100000283 hepatitis Toxicity 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 210000004969 inflammatory cell Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 230000003908 liver function Effects 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 150000007524 organic acids Chemical class 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000000529 probiotic effect Effects 0.000 description 2
- 230000001681 protective effect Effects 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000035899 viability Effects 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108010035563 Chloramphenicol O-acetyltransferase Proteins 0.000 description 1
- 241001076416 Dendrobium tosaense Species 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 208000004930 Fatty Liver Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019133 Hangover Diseases 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 102000008100 Human Serum Albumin Human genes 0.000 description 1
- 108091006905 Human Serum Albumin Proteins 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 108091000080 Phosphotransferase Proteins 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- 241000731396 Pueraria montana var. thomsonii Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 102000007562 Serum Albumin Human genes 0.000 description 1
- 108010071390 Serum Albumin Proteins 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 210000000805 cytoplasm Anatomy 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000001784 detoxification Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- YQGOJNYOYNNSMM-UHFFFAOYSA-N eosin Chemical compound [Na+].OC(=O)C1=CC=CC=C1C1=C2C=C(Br)C(=O)C(Br)=C2OC2=C(Br)C(O)=C(Br)C=C21 YQGOJNYOYNNSMM-UHFFFAOYSA-N 0.000 description 1
- 235000021107 fermented food Nutrition 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 201000007270 liver cancer Diseases 0.000 description 1
- 208000014018 liver neoplasm Diseases 0.000 description 1
- 210000005228 liver tissue Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 230000001338 necrotic effect Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 102000020233 phosphotransferase Human genes 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000002000 scavenging effect Effects 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000007863 steatosis Effects 0.000 description 1
- 231100000240 steatosis hepatitis Toxicity 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/38—Other non-alcoholic beverages
- A23L2/382—Other non-alcoholic beverages fermented
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/488—Pueraria (kudzu)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/744—Gardenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A40/00—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
- Y02A40/90—Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in food processing or handling, e.g. food conservation
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Insects & Arthropods (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Toxicology (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法，属于发酵饮料领域，步骤包括称量、煎煮、混菌发酵、离心、调配灌装、灭菌。本发明产品解酒护肝功效强，复合饮料可显著提高有效成分如葛根素、大豆苷元、栀子苷、黄酮、多酚、二氢杨梅素的含量，从而促进人体对酒精的分解吸收，增强发酵葛根复合饮料的醒酒能力，还能起到滋养脾胃肝肾的功效。
Description
技术领域
本发明涉及发酵饮料技术领域，具体为一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法。
背景技术
酒和酒文化在我国占据着重要地位，饮酒已经深入我们生活中，但饮酒量与不良健康结局的发生风险呈“J型曲线”。全球因饮酒而造成死亡的人数超过273万人，占全球死亡总数的5.2％，其中因饮酒而导致肝硬化和癌症死亡的人数分别占有47.7％和4.2％。酒精性肝病(ALD)是导致人体患慢性肝病的主要原因，ALD包括一系列肝病，主要是从轻度脂肪变性开始，发展为脂肪性肝炎、纤维化和肝硬化。然而，随着时代的发展与进步，人们越来越重视自身健康问题，如何从日常饮食中防止疾病的发生成为人们迫切关注的话题。目前，有众多的具有解酒护肝功效的药品，但长期服用会具有一定的毒性。同样，与解酒功效相关保健品也愈发增多，但由于保健品的价格昂贵，消费者只能“量力而行”。因此，开发一种具有解酒护肝功效且价格亲民的食品为现实所需。
葛根为豆科葛属，《中国药典2010》记载葛根有通经活络，解酒毒之功能。枳椇子作为中医传统解酒毒的中草药，含有大量的二氢杨梅素、有机酸、葡萄糖、有机酸等，具有解酒毒、促进尿液排毒的功效。何会等发现枳椇子葛根中剂量复方能够降低醉酒小鼠血清中的乙醇、乙醛含量，降低醉酒率，能明显加快志愿者酒后的乙醇代谢速度。研究表明，葛花含有的皂角苷、异黄酮类等活性成分能有效地降低酒精在胃肠的吸收，而且可加速乙醛在人和大鼠体内的排除。栀子来源于茜草科植物栀子的干燥成熟果实，有泻火除烦、清热利湿、凉血解毒的功效。
虽已有葛根、葛花、枳椇子单独使用，或与其他药材联合使用进行解酒护肝作用，但在解酒方面尚未见到葛根、葛花、枳椇子、枇杷叶、栀子、铁皮石斛叶六味药材配伍。并且较多解酒饮料的研发均为多种中药材简单配伍，这会使药效不能很好地发挥作用。益生菌和中草药在许多方面有相得益彰的协同作用，利用益生菌发酵中药不仅可以节约中药资源，而且还可以促进其有效成分溶出，降低中药的毒副作用。而现在益生菌发酵主要采用的是单菌种发酵，复合菌种发酵的研究相对较少。本研究旨在通过多种传统中药材的混合制成水煎剂，经混菌发酵，得到一款具有解酒护肝功效的饮品，并探究其解酒的机制，为今后消费者提供酒前或者酒后饮品，从而降低由酒精导致的肝脏疾病机率。
发明内容
为解决上述问题，本发明的目的是提供一种具有解酒护肝功效的葛根复合发酵饮料。
一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法，包括以下步骤：
S1、称量：葛根30-50份、葛花10-20份、枳椇子5-15份、枇杷叶20-40份、栀子10-20份、铁皮石斛叶5-10份；
S2、煎煮：先将药食同源原料于冷水中浸泡30-60min，料水比1:50-1:200，浸泡完成后煎煮30-180min；
S3、混菌发酵：将煎煮好的原液和药材渣一起进行混菌发酵，混菌中乳酸芽孢杆菌：植物乳杆菌＝8:1-1:1，将复合菌种于生理盐水中活化后按1％-5％接种，白砂糖添加量为2％-6％，发酵温度为28℃-36℃，发酵天数为5-14天；
S4、离心:发酵完毕后，将发酵液4000rpm/min离心15min，取上清备用；
S5、调配灌装:向上清液加入山梨酸钾、异维生素C钠、乙基麦芽酚、蜂蜜等进行调配，无氧灌装，得灌装饮料；
S6、灭菌:将灌装饮料放入水浴式灭菌锅内灭菌，于121℃恒温条件下灭菌15-40min，冷却至室温后，得终产品。
优选的，步骤S1中，葛根30份、葛花10份、枳椇子8份、枇杷叶20份、栀子10份、铁皮石斛叶5份。
优选的，步骤S2中，浸泡时间为30min，煎煮时间为60min，料水比1:100。
优选的，步骤S3中，乳酸芽孢杆菌：植物乳杆菌＝4:1。
优选的，步骤S3中，复合菌种于生理盐水中活化后按2％接种，白砂糖添加量为3％，发酵温度为29℃，发酵天数为8天。
本发明的有益效果：
①由对照案例的实验结果表明，添加了铁皮石斛叶和枇杷叶的解酒饮料的醒酒护肝功效比不含这两种中药材的解酒饮料要好，说明添加了这两味药材可起到协同增效的作用，使解酒护肝功效增强。
②益生菌发酵葛根复合饮料可显著提高有效成分如葛根素、大豆苷元、栀子苷、黄酮、多酚、二氢杨梅素的含量，从而促进人体对酒精的分解吸收，增强发酵葛根复合饮料的醒酒能力。相关研究表明葛根素、大豆苷元可降低乙醇的吸收、提高乙醛脱氢酶(ALDH)和乙醇脱氢酶(ADH)的活性，促进乙醇在体内的代谢，从而达到醒酒的目的。而黄酮和多酚具有较强的清除自由基的能力，可减轻肝脏损伤。
③乳酸菌复合发酵过程中可产生乳酸等风味成分赋予葛根发酵复合饮料特殊的发酵食品香气，可改善中药材煎煮后的苦涩味，增加葛根复合饮料的口感，同时还能起到滋养脾胃肝肾的功效。并且药食同源中药材经过微生物的发酵作用，不仅能使有效物质得以溶出，还会产生许多有益于身体平衡的功能因子，将发酵手段应用于饮料制备，开发具有一定功能的以药食两用中药为原料的新型发酵饮料，对于饮料市场结构和产品升级具有重要意义。
④葛根复合饮料采用的是复合菌种发酵。不同的微生物具有不同的酶系，采用多菌种混合发酵，可以使系统的酶系多样化和互补，对于成分复杂的中药生物转化效率更高，多菌种混合发酵还可使植物组织内的功效成分及营养成分得到充分的分解、溶出和利用，提高中药材的综合利用率和生物转化率，从而提高葛根发酵复合饮料的醒酒能力。
⑤调配时，还加入了蜂蜜，蜂蜜中含有丰富的果糖。蜂蜜进入人体时，能快速的被吸收，增加人体的解毒功能，能加速身体里酒精的消解，排出体外，达到解酒的效果。
附图说明
图1：各对比例和实施例对醉酒大鼠血醇浓度影响；
图2：各对比例和实施例中大鼠血清中AST和ALT酶活力；
图3：各对比例和实施例中大鼠血清中CAT和AKP活力；
图4：各对比例和实施例中大鼠血清中Alb含量；
图5：各对比例和实施例的大鼠血清中ADH和ALDH活性；
图6：各对比例和实施例的大鼠肝切片效果图。
其中：
图2中：与对照组比较**P＜0.01，***P＜0.001；与模型组比较##P＜0.01，###P＜0.001；
图3中：与对照组比较**P＜0.01，***P＜0.001；与模型组比较##P＜0.01，###P＜0.001；
图4中：与对照组比较**P＜0.01，***P＜0.001；与模型组比较##P＜0.01，###P＜0.001；
图5中：与对照组比较**P＜0.01，***P＜0.001；与模型组比较##P＜0.01，###P＜0.001。
具体实施方式
下面将结合本发明实施例中的附图表，对本发明的技术方案进行进一步详细的描述，但本发明并不局限于下述实施例。基于本发明中的实施例，在本领域中的普通技术人员没有做出创造性劳动的前提下所取得的所有其他实施例，都属于本发明的保护范围。
一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法，包括以下步骤：
S1、称量：葛根30份、葛花10份、枳椇子8份、枇杷叶20份、栀子10份、铁皮石斛叶5份；
S2、煎煮：先将药食同源原料于冷水中浸泡30min(料液比1：100)，浸泡完成后煎煮60min；
S3、混菌发酵：取煎煮好的原液和药材渣一起进行混菌发酵(乳酸芽孢杆菌：植物乳杆菌＝4:1)，将复合菌种于生理盐水中活化后按2％接种，白砂糖添加量为3％，发酵温度为29℃，发酵天数为8天；
S4、离心:发酵完毕后，将发酵液4000rpm/min离心15min，取上清备用；
S5、调配灌装:加入山梨酸钾、异维生素C钠、乙基麦芽酚、蜂蜜等进行调配，无氧灌装，得灌装饮料；
S6、灭菌:将灌装饮料放入水浴式灭菌锅内灭菌，于121℃恒温条件下灭菌15min，冷却至室温后，得终产品。
实施例2：
一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法，包括以下步骤：
S1、称量：葛根30份、葛花10份、枳椇子8份、枇杷叶20份、栀子10份、铁皮石斛叶5份；
S2、煎煮：先将药食同源原料于冷水中浸泡30min(料液比1：200)，浸泡完成后煎煮90min；
S3、混菌发酵：取煎煮好的原液和药材渣一起进行混菌发酵(乳酸芽孢杆菌：植物乳杆菌＝2:1)，将复合菌种于生理盐水中活化后按2％接种，白砂糖添加量为3％，发酵温度为29℃，发酵天数为8天；
S4、离心:发酵完毕后，将发酵液4000rpm/min离心15min，取上清备用；
S5、调配灌装:加入山梨酸钾、异维生素C钠、乙基麦芽酚、蜂蜜等进行调配，无氧灌装，得灌装饮料；
S6、灭菌:将灌装饮料放入水浴式灭菌锅内灭菌，于121℃恒温条件下灭菌15min，冷却至室温后，得终产品。
实施例3：
一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法，包括以下步骤：
S1、称量：葛根30份、葛花10份、枳椇子8份、枇杷叶20份、栀子10份、铁皮石斛叶5份；
S2、煎煮：先将药食同源原料于冷水中浸泡30min(料液比1：50)，浸泡完成后煎煮120min；
S3、混菌发酵：取煎煮好的原液和药材渣一起进行混菌发酵(乳酸芽孢杆菌：植物乳杆菌＝1:1)，将复合菌种于生理盐水中活化后按2％接种，白砂糖添加量为3％，发酵温度为29℃，发酵天数为8天；
S4、离心:发酵完毕后，将发酵液4000rpm/min离心15min，取上清备用；
S5、调配灌装:加入山梨酸钾、异维生素C钠、乙基麦芽酚、蜂蜜等进行调配，无氧灌装，得灌装饮料；
S6、灭菌:将灌装饮料放入水浴式灭菌锅内灭菌，于121℃恒温条件下灭菌15min，冷却至室温后，得终产品。
对比例1：
一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法，包括以下步骤：
步骤S1的原料无枇杷叶和铁皮石斛叶，且无步骤S3，其余与实施例1相同。
对比例2：
一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法，包括以下步骤：
除无步骤S3以外，其余与实施例1相同。
对比例3：为市售的一款解酒产品。
实验例1：葛根复合发酵饮料的感官评定
表1各对比例和实施例感官评价的评判标准
表2各对比例和实施例感官评定结果
经对各对比例和实施例进行感官评定，实施例1的感官评分最高，甜度、酸度、香味、口感均为最佳。
实验例2：发酵前后葛根饮料化学成分的变化
表3各对比例和实施例的化学成分变化
实验例3：葛根复合发酵饮料的降血醇作用
1.1实验动物
SPF级SD雄性大鼠64只，180-200g，随机分为8组，每组8只，分别为模型组；阳性对照组；对比案例1、2、3；实施案例1、2、3。动物由广东省医学实验动物中心提供，许可证号：SCXK(粤)2018-0002。
1.2实验方法
建立急性酒精性肝损伤模型模型。适应性喂养一周后，各组大鼠灌胃相应的样品，2次/天，间隔4h，末次给药30min后，按照大鼠体重灌胃给予43度红星二锅头白酒6mL/kg，正常组给予生理盐水。酒精灌胃后的1h，2h，4h三个时间段收集大鼠的血液，分离血清测血醇的浓度。
1.3实验结果
1.3.1葛根复合发酵饮料的降血醇作用
由图1可知，与模型组相比，实施案例1、实施案例2、实施案例3能够明显抑制醉酒大鼠血液乙醇浓度的升高，并且实施案例1的效果最优，其能够更快将血醇浓度降低至较低水平。说明实施案例1可以起到很好的降血醇作用。
实验例4：各对比例和实施例大鼠的解酒机制研究
1.1实验动物
SPF级SD雄性大鼠90只，180-200g，按照体重随机分为9组，每组10只，分别为正常组；模型组；阳性对照组；对照案例1、2、3；实施案例1、2、3。大鼠由广东省医学实验动物中心提供，许可证号：SCXK(粤)2018-0002。
1.2实验方法
样品组的大鼠按照1mL/100g灌胃相应的样品，1天一次，持续7d，末次灌胃样品4h后，继续灌胃12mL/kg的43度红星二锅头白酒。禁食不禁水8h后处死大鼠。采集血液和肝脏。血液用生化管收集后冷冻离心，解剖取肝脏，用0.9％生理盐水冲洗，用滤纸吸干多余水分后称肝脏重量。肝脏用10％中性福尔马林固定，石蜡包埋，切成5μm的切片，苏木精伊红(H&E)染色观察肝组织病理学特征。
动物血液在4℃下离心，以4000r/min转速下离心10min。分离上清得到的淡黄色液体，即为血清，于-80℃条件下储存，待测。
1.3实验结果
1.3.1各对比例和实施例对大鼠体重和肝脏的影响
肝脏遭受酒精损伤时，会呈现细胞肿大情况，同时在脂肪代谢过程中，还易出现代谢紊乱现象，使脂肪堆积在肝细胞中，造成肝脏整体质量和体积的增加，肝脏指数异常升高。由表4可知，除正常组外，模型组的肝脏指数大于其他组别，说明模型组大鼠的肝脏受到了一定损伤。正常组高的原因可能与其正常生长导致体重差异造成的，对照例和实施案例组的肝脏指数相较于模型组均显著降低，且实施案例1降低水平最显著(P＜0.01)。表明实施案例1对酒精作用下的肝脏有一定的保护效果。
表4各对比例和实施例大鼠体重和肝重的变化
注：与对照组比较**p＜0.01；与模型组比较##p＜0.01。
1.3.2各对比例和实施例对大鼠血清AST、ALT活力影响
由酒精介导的氧化应激引发的肝功能异常，导致血清中天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)等肝酶的释放、脂质过氧化、抗氧化功能丧失。因此，AST、ALT酶活性的大小可以用于衡量肝功能的受损程度。如图2所示，酒精建模后，模型组血清中AST活力相较于对照组极显著升高(P＜0.001)。对照例和实施例大鼠血清中ALT、AST活力相较于模型组均有不同程度的降低(P＜0.05、P＜0.01或P＜0.001)，并且实施案例1降低最显著。由此可见，实施案例1能有效减轻因酒精作用导致的ALT、AST水平异常升高，对酒精性肝损伤有一定的保护效果。
1.3.3各对比例和实施例对大鼠血清氧化应激酶影响
越来越多的证据表明，氧化能力在酒精性肝损伤中扮演着重要的作用。氧化系统最重要的是酶，如SOD，CAT，GSH-Px等，这些酶能够保护机体免受活性氧的破坏，并且急性酒精中毒能够导致大鼠肝脏中AKP活力升高和CAT酶活力降低，因此，评价体内酶活力大小能够反映机体抗氧化能力的强弱以及葛根发酵饮料是否增强其机体内的抗氧化能力。如图3所示，与正常组相比，模型组中AKP活力显著升高，CAT活力显著下降，且达到极显著水平，说明急性酒精中毒模型成功。而实施案例1能够降低由酒精导致的AKP活力升高，其降低效果达到极显著水平，并且能在一定程度上能够提高CAT的活力。说明实施案例1可以降低肝脏中AKP的氧化应激能力和提高CAT的活力来达到保肝的效果，提示着葛根发酵复合饮料可以缓解氧化应激损伤。
1.3.4各对比例和实施例对大鼠血清白蛋白的影响
一般正常人的白蛋白(Alb)在60-80g/L之间，假如超出这个范围，说明肝脏有一定的受损。因此，血清中白蛋白含量在一定程度上能够反映大鼠由急性酒精性中毒导致的肝炎情况。如图4所示，与正常组相比，模型组Alb含量显著上升(P＜0.001)，说明急性酒精中毒对血清中白蛋白有显著影响。与模型组相比，对照例和实施例大鼠的Alb含量均有不同程度的下降，并且实施案例1大鼠的Alb含量下降最显著(P＜0.001)，预示着该发酵复合饮料能够减少急性酒精中毒导致的肝炎的发生。
1.3.5各对比例和实施例对大鼠血清中ADH、ALDH活力的影响
对于饮酒大鼠，部分酒精被血管吸收并通过血液中的乙醇脱氢酶氧化，再被乙醛脱氢酶氧化而代谢，酒精的代谢非常依赖于乙醇脱氢酶和乙醛脱氢酶的活性，因此评价ADH和ALDH对酒精性肝损伤有积极意义。如图5所示，与正常组比较，模型组大鼠血清中ADH，ALDH活性降低，而给予灌胃各对照例和实施例样品可增加饮酒大鼠血清中ADH，ALDH活性。其中实施案例中的案例1显著增强ADH，ALDH的活性。由此可得该发明可通过增强大鼠血清中ADH和ALDH的活性来快速代谢酒精，使酒精含量降低，达到护肝的作用。
1.3.6各对比例和实施例对大鼠肝脏细胞的影响
如图6所示，空白对照组大鼠肝细胞结构正常，形态规整，细胞核呈圆形，整体细胞染色均匀，间隔清晰，未见变性坏死细胞和炎细胞浸润现象。模型组大鼠肝组织出现严重病变，组织结构紊乱，中央静脉显著扩大且严重变形，肝细胞肿胀甚至发生崩解，出现成片坏死现象，细胞核碎裂、溶解严重，胞浆稀松，细胞间间隙模糊，可见小泡性脂变，且炎症细胞浸润现象严重。各对照案例和实施案例的大鼠肝细胞组织损伤得到显著改善，细胞核破裂现象减少、肝细胞肿胀崩解程度减轻，炎性浸润和空泡变性等情况都有所减轻，表明葛根复合发酵饮料可有效改善急性酒精性肝损伤。
对于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
此外，应当理解，虽然本说明书按照实施方式加以描述，但并非每个实施方式仅包含一个独立的技术方案，说明书的这种叙述方式仅仅是为清楚起见，本领域技术人员应当将说明书作为一个整体，各实施例中的技术方案也可以经适当组合，形成本领域技术人员可以理解的其他实施方式。
Claims (4)
1.一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法，其特征在于，包括以下步骤：
S1、称量：葛根30份、葛花10份、枳椇子8份、枇杷叶20份、栀子10份、铁皮石斛叶5份；
S2、煎煮：先将药食同源原料于冷水中浸泡30-60min，料水比1:50-1:200，浸泡完成后煎煮30-180min；
S3、混菌发酵：将煎煮好的原液和药材渣一起进行混菌发酵，混菌中乳酸芽孢杆菌：植物乳杆菌＝8:1-1:1，将复合菌种于生理盐水中活化后按1％-5％接种，白砂糖添加量为2％-6％，发酵温度为28℃-36℃，发酵天数为5-14天；
S4、离心：发酵完毕后，将发酵液4000rpm离心15min，取上清备用；
S5、调配灌装：向上清液加入山梨酸钾、异维生素C钠、乙基麦芽酚、蜂蜜进行调配，无氧灌装，得灌装饮料；
S6、灭菌：将灌装饮料放入水浴式灭菌锅内灭菌，于121℃恒温条件下灭菌15-40min，冷却至室温后，得终产品。
2.根据权利要求1所述的具有醒酒护肝功效的葛根复合发酵饮料的制备方法，其特征在于，步骤S2中，浸泡时间为30min，煎煮时间为60min，料水比1:100。
3.根据权利要求1所述的具有醒酒护肝功效的葛根复合发酵饮料的制备方法，其特征在于，步骤S3中，乳酸芽孢杆菌：植物乳杆菌＝4:1。
4.根据权利要求1所述的具有醒酒护肝功效的葛根复合发酵饮料的制备方法，其特征在于，步骤S3中，复合菌种于生理盐水中活化后按2％接种，白砂糖添加量为3％，发酵温度为29℃，发酵天数为8天。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210145128.1A CN114514973B (zh) | 2022-02-17 | 2022-02-17 | 一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210145128.1A CN114514973B (zh) | 2022-02-17 | 2022-02-17 | 一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN114514973A CN114514973A (zh) | 2022-05-20 |
| CN114514973B true CN114514973B (zh) | 2023-09-05 |
Family
ID=81598130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210145128.1A Active CN114514973B (zh) | 2022-02-17 | 2022-02-17 | 一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN114514973B (zh) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN116138382B (zh) * | 2022-12-29 | 2024-07-26 | 河南省安康未来食品科技有限公司 | 一种真空射频辅助生物酶解制备植物饮品的方法 |
| CN116831285A (zh) * | 2023-07-12 | 2023-10-03 | 广州崧源农业科技有限公司 | 一种葛根发酵产物及其在制备植物饮品的应用 |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009069921A2 (en) * | 2007-11-30 | 2009-06-04 | Korea Institute Of Oriental Medicine | Composition for alleviation of alcohol induced hangover comprising hovenia dulcis thunberg contained ssangwhatang |
| CN104784295A (zh) * | 2015-04-27 | 2015-07-22 | 无限极（中国）有限公司 | 一种解酒护肝中药组合物及其制备方法 |
| CN106107754A (zh) * | 2016-07-04 | 2016-11-16 | 佛山科学技术学院 | 一种铁皮石斛叶果冻及其制备方法 |
| CN110050928A (zh) * | 2019-06-10 | 2019-07-26 | 司武阳 | 一种拐枣乳酸菌发酵饮料配方及其制备方法 |
| CN110214929A (zh) * | 2019-06-14 | 2019-09-10 | 华南农业大学 | 一种铁皮石斛叶发酵调味酱及其制作方法 |
| CN110897147A (zh) * | 2019-11-18 | 2020-03-24 | 贵州同威生物科技有限公司 | 铁皮石斛解酒保肝组合物和制法 |
| CN111406856A (zh) * | 2020-03-11 | 2020-07-14 | 天津科技大学 | 一种解酒护肝功能性发酵饮料及其制备方法 |
| CN111973673A (zh) * | 2020-09-11 | 2020-11-24 | 华南农业大学 | 一种加快陈皮陈化的方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2004276123B2 (en) * | 2003-09-26 | 2008-06-26 | Biomedical Research Group Inc. | Fermentation and culture method, fermented plant extract, fermented plant extract powder and composition containing the fermented plant extract |
-
2022
- 2022-02-17 CN CN202210145128.1A patent/CN114514973B/zh active Active
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009069921A2 (en) * | 2007-11-30 | 2009-06-04 | Korea Institute Of Oriental Medicine | Composition for alleviation of alcohol induced hangover comprising hovenia dulcis thunberg contained ssangwhatang |
| CN104784295A (zh) * | 2015-04-27 | 2015-07-22 | 无限极（中国）有限公司 | 一种解酒护肝中药组合物及其制备方法 |
| CN106107754A (zh) * | 2016-07-04 | 2016-11-16 | 佛山科学技术学院 | 一种铁皮石斛叶果冻及其制备方法 |
| CN110050928A (zh) * | 2019-06-10 | 2019-07-26 | 司武阳 | 一种拐枣乳酸菌发酵饮料配方及其制备方法 |
| CN110214929A (zh) * | 2019-06-14 | 2019-09-10 | 华南农业大学 | 一种铁皮石斛叶发酵调味酱及其制作方法 |
| CN110897147A (zh) * | 2019-11-18 | 2020-03-24 | 贵州同威生物科技有限公司 | 铁皮石斛解酒保肝组合物和制法 |
| CN111406856A (zh) * | 2020-03-11 | 2020-07-14 | 天津科技大学 | 一种解酒护肝功能性发酵饮料及其制备方法 |
| CN111973673A (zh) * | 2020-09-11 | 2020-11-24 | 华南农业大学 | 一种加快陈皮陈化的方法 |
Non-Patent Citations (1)
| Title |
|---|
| 北京中医学中药等研室.药性歌括四百味白话解 修订版.人民卫生出版社,1995,第129页. * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN114514973A (zh) | 2022-05-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN114514973B (zh) | 一种具有醒酒护肝功效的葛根复合发酵饮料的制备方法 | |
| CN104664512B (zh) | 一种可提高免疫力的甘草植物饮料及其制备方法 | |
| CN109880732A (zh) | 一种解酒护肝果醋饮料及其制备方法 | |
| CN104757670B (zh) | 一种甘草保健植物饮料及其制备方法 | |
| CN104087488A (zh) | 一种树莓复合果酒及其酿造方法 | |
| CN104383315A (zh) | 一种护肝醒酒的中草药组合物及含有该组合物的饮品 | |
| CN106343295B (zh) | 一种具有纤体美容功能的树莓饮料及其制备方法 | |
| CN105639381A (zh) | 脐橙火龙果酵素保健饮料的制作方法 | |
| CN110862897A (zh) | 桑叶蚕蛹黄酒及制造工艺 | |
| CN110106044A (zh) | 一种白桑葚白葡萄果酒及其制备方法 | |
| CN106235318A (zh) | 以金银花、姜黄为主要原料制备酵素的方法 | |
| CN1279111A (zh) | 生物酶解酒营养液及其制备方法 | |
| CN103497867B (zh) | 芒果香蕉果酒及其生产方法 | |
| CN106822622A (zh) | 一种解酒护肝口服组合物及其制备方法 | |
| CN104664513A (zh) | 一种甘草植物饮料及其制备方法 | |
| CN107236643A (zh) | 一种百香果酒的制备方法 | |
| CN111621388A (zh) | 一种抗疲劳的黑菊芋果酒及其制备方法 | |
| CN102488744A (zh) | 一种解酒毒的药物及其制备方法 | |
| CN113388485A (zh) | 一种解酒护肝玫瑰果醋饮料的制备方法 | |
| CN108719713A (zh) | 一种广陈皮保健饮品及其制备方法 | |
| CN113318161A (zh) | 一种解酒护肝组合物及其制备方法 | |
| CN113925102A (zh) | 一种具有解酒养肝，清热止渴作用的凉草茶及其制备方法 | |
| CN114631632A (zh) | 一种护肝解酒的刺梨组合物及其制剂与应用 | |
| CN103843902B (zh) | 一种含有葛根的液态乳制品及其制备方法 | |
| KR101982816B1 (ko) | 함초를 포함하는 숙취해소 및 간기능 개선용 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20231031 Address after: 510642 Guangdong city of Guangzhou province Tianhe District Wushan South China Agricultural University Patentee after: SOUTH CHINA AGRICULTURAL University Patentee after: GUANGZHOU SONGYUAN AGRICULTURAL TECHNOLOGY Co.,Ltd. Address before: 510642 Guangdong city of Guangzhou province Tianhe District Wushan South China Agricultural University Patentee before: SOUTH CHINA AGRICULTURAL University |